Evaluation of the efficacy of rosuvastatin in daily practice (TARGET)

Study identifier:25V06

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Evaluation of the efficacy of rosuvastatin in daily practice (TARGET)

Medical condition

Hypercholesterolemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3889

Study type

Observational

Age

18 Years - 75 Years

Date

Study Start Date: 01 Feb 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria